Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Retained Earnings (2019 - 2025)

Korro Bio (KRRO) has disclosed Retained Earnings for 6 consecutive years, with $214000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Retained Earnings fell 62.72% year-over-year to $214000.0, compared with a TTM value of $214000.0 through Sep 2025, down 62.72%, and an annual FY2024 reading of $268000.0, up 100.15% over the prior year.
  • Retained Earnings was $214000.0 for Q3 2025 at Korro Bio, up from -$315.7 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $574000.0 in Q3 2024 and bottomed at -$315.7 million in Q2 2025.
  • Average Retained Earnings over 5 years is -$142.9 million, with a median of -$158.6 million recorded in 2021.
  • Peak annual rise in Retained Earnings hit 100.19% in 2024, while the deepest fall reached 3739700.0% in 2024.
  • Year by year, Retained Earnings stood at -$180.1 million in 2021, then skyrocketed by 43.45% to -$101.8 million in 2022, then tumbled by 79.71% to -$183.0 million in 2023, then surged by 100.15% to $268000.0 in 2024, then fell by 20.15% to $214000.0 in 2025.
  • Business Quant data shows Retained Earnings for KRRO at $214000.0 in Q3 2025, -$315.7 million in Q2 2025, and -$290.0 million in Q1 2025.